Ativan Tablets

Name: Ativan Tablets

Indications and Usage for Ativan Tablets

Ativan (lorazepam) is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic.

The effectiveness of Ativan (lorazepam) in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.

PRINCIPAL DISPLAY PANEL - 0.5 mg Bottle Label

NDC 0187-0063-01

Ativan®
(lorazepam)

0.5 mg

100 Tablets

CIV
SEALED
FOR YOUR
PROTECTION

Rx only

VALEANT

ATIVAN 
lorazepam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0187-0063
Route of Administration ORAL DEA Schedule CIV    
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
lorazepam (lorazepam) lorazepam 0.5 mg
Inactive Ingredients
Ingredient Name Strength
lactose monohydrate  
MAGNESIUM STEARATE  
POLACRILIN POTASSIUM  
cellulose, microcrystalline  
Product Characteristics
Color WHITE Score no score
Shape PENTAGON (5 sided) (SHIELD SHAPE) Size 5mm
Flavor Imprint Code A;BPI;63
Contains     
Packaging
# Item Code Package Description
1 NDC:0187-0063-01 100 TABLET in 1 BOTTLE
2 NDC:0187-0063-50 500 TABLET in 1 BOTTLE
3 NDC:0187-0063-10 1000 TABLET in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017794 05/01/2013
ATIVAN 
lorazepam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0187-0064
Route of Administration ORAL DEA Schedule CIV    
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
lorazepam (lorazepam) lorazepam 1 mg
Inactive Ingredients
Ingredient Name Strength
lactose monohydrate  
MAGNESIUM STEARATE  
POLACRILIN POTASSIUM  
cellulose, microcrystalline  
Product Characteristics
Color WHITE Score 2 pieces
Shape PENTAGON (5 sided) (SHIELD SHAPE) Size 6mm
Flavor Imprint Code A;BPI;64
Contains     
Packaging
# Item Code Package Description
1 NDC:0187-0064-01 100 TABLET in 1 BOTTLE
2 NDC:0187-0064-50 500 TABLET in 1 BOTTLE
3 NDC:0187-0064-10 1000 TABLET in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017794 05/01/2013
ATIVAN 
lorazepam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0187-0065
Route of Administration ORAL DEA Schedule CIV    
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
lorazepam (lorazepam) lorazepam 2 mg
Inactive Ingredients
Ingredient Name Strength
lactose monohydrate  
MAGNESIUM STEARATE  
POLACRILIN POTASSIUM  
cellulose, microcrystalline  
Product Characteristics
Color WHITE Score 2 pieces
Shape PENTAGON (5 sided) (SHIELD SHAPE) Size 7mm
Flavor Imprint Code A;2;BPI;65
Contains     
Packaging
# Item Code Package Description
1 NDC:0187-0065-01 100 TABLET in 1 BOTTLE
2 NDC:0187-0065-50 500 TABLET in 1 BOTTLE
3 NDC:0187-0065-10 1000 TABLET in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017794 05/01/2013
Labeler - Valeant Pharmaceuticals North America LLC (042230623)
Establishment
Name Address ID/FEI Operations
MEDA Manufacturing GmbH 329238187 MANUFACTURE(0187-0063, 0187-0064, 0187-0065)
Revised: 12/2016   Valeant Pharmaceuticals North America LLC
(web3)